Business Wire

MÉRIEUX-EQUITY

18.2.2021 08:02:12 CET | Business Wire | Press release

Share
AcuSurgical raises €5.75 Million in Series A financing, to advance its robotic ocular microsurgery platform.

AcuSurgical, a Montpellier-based company focused on robotic microsurgery, today announces a €5.75 million Series A financing round led by Mérieux Equity Partners (via OMX Europe Venture Fund) and Supernova Invest (via Supernova 2 Fund), with Sofimac Innovation (via Pertinence Invest 2 Fund) and IRDI Capital Investissement (via Irdinov 2 and Inn’Vest PME Occitanie Est Funds) participating in the round.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210217005035/en/

Using advanced robotics, AcuSurgical is making ocular microsurgery safer and more accessible by dramatically improving the precision of surgical interventions. A proof of concept of the platform has already been completed with a first prototype validated in a preclinical setting.

The company will use the proceeds of the Series A financing to conduct clinical trials and reach regulatory approval with vitreo-retinal surgery as the first indication, paving the way for future applications that are not within the reach of surgeons today.

Retinal surgeries represent an annual global market of 1.6 million procedures, currently performed by a limited number of specialized surgeons. AcuSurgical’s robotic platform aims to increase the precision of current procedures, filtering tremor and augmenting visualization with the aid of a telemanipulated robot, while the surgeon remains in complete control.

Founded by Christoph Spuhler, serving as Chief Executive Officer, AcuSurgical has already attracted an experienced and highly skilled multidisciplinary team of executives, alongside the scientific co-founders, Prof. Yassine Haddab and Prof. Philippe Poignet, robotics experts at the joint research Unit LIRMM (Laboratory of Computer Science, Robotics and Microelectronics in Montpellier) and Prof. Philippe Gain and Prof. Gilles Thuret, retinal surgeons at the Saint-Etienne University Hospital.

“Our ambition is to enable new treatments for retinal disease that will open new perspectives for the numerous patients who are impacted by these debilitating retinal conditions. We are proud of the vote of confidence by this strong syndicate of investors. This financing will allow us to grow the team and reach key milestones towards certification and commercialisation of a truly innovative surgical solution”, s ays Christoph Spuhler, CEO and co-founder of AcuSurgical.

“We are delighted to partner with such an experienced team and look forward to supporting AcuSurgical in bringing to market a novel solution that will improve ocular surgeries and open new procedures in ophthalmology” , says Valérie Calenda, Managing Partner at Mérieux Equity Partners.

”The robotics platform developed by AcuSurgical aims to help retinal surgeons perform complex procedures more safely and reproducibly. We are very pleased to support this new venture and excellent team” says Celia Hart, General Partner at Supernova Invest.

About AcuSurgical - www.acusurgical.com

Founded in 2020, AcuSurgical is a surgical robotics company based in Montpellier (France). AcuSurgical's mission is to enable top-class treatment to the 300+ million patients suffering from retinal disease worldwide, a debilitating condition including age-related macular degeneration (AMD), diabetic retinopathy and macular holes. Worldwide, currently 1.6 million retinal surgeries are performed each year, with a yearly growth rate of 7%. This currently represents only a small percentage of actual cases, with the majority of patients, especially in emerging economies, getting inadequate treatment or often no treatment at all. The cutting-edge robotics platform from AcuSurgical aims to change this, bringing a new surgical paradigm to vitreo-retinal surgery based on precision robotics.

About Mérieux Equity Partners - www.merieux-partners.com

Mérieux Equity Partners (“MxEP”) is an investment company dedicated to capital investment in health and nutrition and registered with the Autorité des Marchés Financiers (AMF). MxEP actively supports entrepreneurs and companies with differentiated products and services, giving them privileged access to its sector expertise and international network. MxEP currently manages around €670 million of assets and launched their latest venture capital fund in 2020, OMX Venture Fund, to finance high potential companies in the life science space, in Europe and North America.

About Supernova Invest - www.supernovainvest.com

Supernova Invest is a cutting-edge venture capital firm with a leading position in the French deeptech investment market. It manages and advises five capital funds for a total of €260 million AUM. Supernova Invest specializes in breakthrough technologies, developing start-ups in Industry, Health, Energy & Environment and Digital Technology sectors. Supernova Invest has a strong partnership with both the CEA (the French Alternative Energies and Atomic Energy Commission) and Amundi (the European leader in asset management).

The FPCI Supernova 2 is an early-stage investment fund managed by Supernova Invest. Its main investors are the Crédit Agricole, the Fond National d’Amorçage managed by Bpi France, the CEA, Michelin, BioMérieux, Vinci, EDF, CGG, UDIMEC as well as entrepreneurs and family offices.

About Sofimac Innovation - www.sofimacinnovation.com

Sofimac Innovation is an independent management company certified by the financial markets regulator (AMF) and dedicated to technological and innovative investment. Based in Paris, Lyon, Rennes and Marseille, Sofimac Innovation supports innovative start-up in their growth projects with a wide range of investment vehicles. Working in a wide variety of technological sectors, particularly in Health and Digital sectors, Sofimac Innovation is currently managing 9 Funds comprising around 90 active companies.

Pertinence Invest 2 is an investment Fund managed by Sofimac Innovation, raised in partnership with prestigious Universities and Schools and renowned industrial corporates. Pertinence Invest 2 is investing in breakthrough technologies in the Engineering Sciences and Health & Nutrition sectors.

About IRDI Capital Investissement - www.irdi.fr

Based in Toulouse, Montpellier, and Bordeaux, IRDI Capital Investissement has been a key player in private equity for more than 35 years, with an investment track record in companies located in the South-West of France and at all development stages. It manages more than €350 million spread across several funds, including IRDINOV 2 and INN’VEST PME OCCITANIE EST which were both leveraged to invest in AcuSurgical.

IRDINOV 2 - supported by the Fonds National d’Amorçage (FNA) - is a capital seed fund specialized in financing technological companies.

INN’VEST PME OCCITANIE EST is a co-investment fund supported by the European Investment Fund (EIF) and the Région Occitanie under the FOSTER TPE PME fund of funds.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Allianz Achieves Record Operating Profit of 17.4 Billion Euros – Excellent Start to New Strategic Cycle26.2.2026 07:16:00 CET | Press release

12M 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225107874/en/ Oliver Bäte, Chief Executive Officer of Allianz SEExcellent momentum and record operating profitTotal business volume rises 8.11 percent and reaches 186.9 billion euros with contributions from all segments Operating profit increases 8.4 percent to 17.4 billion euros, our highest operating profit ever Shareholders’ core net income advances 10.9 percent to 11.1 billion euros Core earnings per share (EPS) grow 12.5 percent and reach 28.61 euros Core return on equity (RoE) reaches an excellent level of 18.1 percent Solvency IIratio2 increases 10 percentage points to 218 percent supported by excellent capital generation 4Q 2025 Diversified growth and double-digit increase in shareholders’ core net incomeTotal business volume rises 6.5 1 percent with contributions from all segments Operating profit increases 3.0 percent to 4.3 billion euros, driven by excelle

Tigo Energy Showcases Real-time Active Commissioning Software at KEY 2026 Expo26.2.2026 06:00:00 CET | Press release

Next-generation commissioning system designed to help streamline solar installations delivers another Total Quality Solar innovation as Tigo expands installer loyalty program Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo,” “Company”), a leading provider of intelligent solar and energy software solutions, today announced the Company’s presence as an exhibitor at the 2026 KEY – The Energy Transition Expo in Rimini, Italy, where Tigo will preview the new active commissioning software. From basic solar-only installations to advanced solar-plus-storage configurations, the system supports installers throughout the entire jobsite workflow via the Tigo EI App, delivering on-site guidance, real-time progress visibility, and clear verification of every required step to help reduce delays, truck rolls, and commissioning uncertainty. At KEY 2026, Tigo will also showcase the latest expansions to the Installer Loyalty Program, including new eligibility tiers and segments, enhanced data support for install

Indra Group Exceeds All Its Guidances in 2025 and Sets Even More Ambitious Guidances for 2026 Than Those Set Out in Its 'Leading the Future' Strategic Plan25.2.2026 23:08:00 CET | Press release

Results in fiscal year 2025Revenues increased by 13%, totaling €5.457 billion in 2025Indra Group sets financial guidances at least 17% higher than those foreseen in its Strategic Plan for 2026Indra Group announces thepayment of a €0.30 dividend per share (more than 20% above the dividend in 2024) charged to the earnings posted in 2025The results and the increase in the order intake confirm Indra Group’s industrial strength and its capacity to tackle and execute the major defence modernization programs Indra Group (MAD:IDR): • The fourth-quarter order intake in 2025 totaled €8.329 billion, raising thefull-year backlog to €16.083 billion (122% more than in 2024). The Defence backlog stood at €11.336 billion, far exceeding the target of more than €10 billion set for 2026. • Revenues increased by 13% in 2025 with respect to 2024, with double-digit year-on-year rises in Defence, ATM and Mobility Revenues recorded a 28% year-on-year rise in the final quarter of the year • EBITDA and EBIT rec

Belkin Introduces a New Accessory Collection for Samsung Galaxy S26 Series25.2.2026 19:00:00 CET | Press release

Including five ‘Designed for Samsung’ accessories plus more, the collection is engineered and optimized specifically for the Samsung Galaxy S26 seriesFrom fast Qi2 25W charging to Nano-Titan–enhanced screen protection, each product is engineered for everyday performance and durabilityThe lineup reinforces Belkin’s role as a trusted partner for next-generation Galaxy devices Belkin, a leading consumer electronics brand for over 40 years, today announced a new collection of accessories designed and optimized specifically for the Samsung Galaxy S26 series. From fast, reliable Qi2 25W charging to advanced screen protection engineered for ultrasonic fingerprint sensors and next-generation displays, every product in the collection is designed to meet the demands of Galaxy S26 users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225459906/en/ Belkin Introduces a New Accessory Collection for Samsung Galaxy S26 Series ‘Designed f

Andersen Consulting udvider sine kompetencer med Assure Consulting25.2.2026 18:58:00 CET | Pressemeddelelse

Andersen Consulting styrker sin platform med tilføjelsen af samarbejdspartneren Assure Consulting, et tysk managementkonsulentfirma med speciale i projektledelse og projektporteføljestyring. Assure Consulting blev grundlagt i 2003 og hjælper organisationer med at gennemføre komplekse projekter og transformationer. Firmaet hjælper kunder med at etablere og drive projektkontorer (PMO'er), styrke governance og porteføljestyring samt anvende klassiske, agile eller hybride projektledelsesmetoder, der er skræddersyet til deres behov. Assure Consulting yder også praktisk støtte til udrulning af store systemer og processer, integreret forandringsledelse i forbindelse med organisatoriske og kulturelle transformationer samt coaching- og træningsprogrammer, der er i overensstemmelse med internationalt anerkendte standarder for projektledelse, med henblik på at opbygge bæredygtige kompetencer i kundernes organisationer. "Dette samarbejde giver os mulighed for at skalere vores ekspertise inden for

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye